These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 20699234)

  • 61. The central role of chromatin in autoimmune responses to histones and DNA in systemic lupus erythematosus.
    Burlingame RW; Boey ML; Starkebaum G; Rubin RL
    J Clin Invest; 1994 Jul; 94(1):184-92. PubMed ID: 8040259
    [TBL] [Abstract][Full Text] [Related]  

  • 62. 4-Hydroxy-2-nonenal modified histone-H2A: a possible antigenic stimulus for systemic lupus erythematosus autoantibodies.
    Alzolibani AA; Al Robaee AA; Al-Shobaili HA; Rasheed Z
    Cell Immunol; 2013; 284(1-2):154-62. PubMed ID: 23973878
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Immunization with an apoptotic cell-binding protein recapitulates the nephritis and sequential autoantibody emergence of systemic lupus erythematosus.
    Levine JS; Subang R; Nasr SH; Fournier S; Lajoie G; Wither J; Rauch J
    J Immunol; 2006 Nov; 177(9):6504-16. PubMed ID: 17056583
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Specificities and clinical significance of autoantibodies directed against histones].
    Suwa A
    Nihon Rinsho Meneki Gakkai Kaishi; 2005 Jun; 28(3):123-30. PubMed ID: 15997175
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Glomerular targets for autoantibodies in lupus nephritis--an apoptotic origin.
    Zykova SN; Seredkina NE; Rekvig OP
    Ann N Y Acad Sci; 2007 Jun; 1108():1-10. PubMed ID: 17893965
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Epigenetic perspectives in systemic lupus erythematosus: pathogenesis, biomarkers, and therapeutic potentials.
    Zhao S; Long H; Lu Q
    Clin Rev Allergy Immunol; 2010 Aug; 39(1):3-9. PubMed ID: 19639427
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Sialylation of anti-histone immunoglobulin G autoantibodies determines their capabilities to participate in the clearance of late apoptotic cells.
    Magorivska I; Muñoz LE; Janko C; Dumych T; Rech J; Schett G; Nimmerjahn F; Bilyy R; Herrmann M
    Clin Exp Immunol; 2016 Apr; 184(1):110-7. PubMed ID: 26618514
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Antibodies from systemic lupus erythematosus (SLE) sera define differential release of autoantigens from cell lines undergoing apoptosis.
    Huggins ML; Todd I; Cavers MA; Pavuluri SR; Tighe PJ; Powell RJ
    Clin Exp Immunol; 1999 Nov; 118(2):322-8. PubMed ID: 10540198
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Epigenetic dysregulation in systemic lupus erythematosus.
    Liu A; La Cava A
    Autoimmunity; 2014 Jun; 47(4):215-9. PubMed ID: 24128164
    [TBL] [Abstract][Full Text] [Related]  

  • 70. New insights into the immunopathogenesis of systemic lupus erythematosus.
    Tsokos GC; Lo MS; Costa Reis P; Sullivan KE
    Nat Rev Rheumatol; 2016 Nov; 12(12):716-730. PubMed ID: 27872476
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Dysregulation of Cell Death and Its Epigenetic Mechanisms in Systemic Lupus Erythematosus.
    Wu H; Fu S; Zhao M; Lu L; Lu Q
    Molecules; 2016 Dec; 22(1):. PubMed ID: 28035990
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Immunopathogenesis of lupus and lupus nephritis: recent insights.
    Kewalramani R; Singh AK
    Curr Opin Nephrol Hypertens; 2002 May; 11(3):273-7. PubMed ID: 11981256
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Monoclonal anti-histone H1 autoantibodies from MRL lpr/lpr mice.
    Monestier M; Fasy TM; Böhm L
    Mol Immunol; 1989 Aug; 26(8):749-58. PubMed ID: 2811870
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Basophils and nephritis in lupus.
    Kaveri SV; Mouthon L; Bayry J
    N Engl J Med; 2010 Sep; 363(11):1080-2. PubMed ID: 20825323
    [No Abstract]   [Full Text] [Related]  

  • 75. Altered patterns of epigenetic changes in systemic lupus erythematosus and auto-antibody production: is there a link?
    Thabet Y; Cañas F; Ghedira I; Youinou P; Mageed RA; Renaudineau Y
    J Autoimmun; 2012 Sep; 39(3):154-60. PubMed ID: 22709855
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The effect of cell death in the initiation of lupus nephritis.
    Fenton K
    Clin Exp Immunol; 2015 Jan; 179(1):11-6. PubMed ID: 25041590
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Defective DNA repair and chromatin organization in patients with quiescent systemic lupus erythematosus.
    Souliotis VL; Vougas K; Gorgoulis VG; Sfikakis PP
    Arthritis Res Ther; 2016 Aug; 18(1):182. PubMed ID: 27492607
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The in vivo expression of actin/salt-resistant hyperactive DNase I inhibits the development of anti-ssDNA and anti-histone autoantibodies in a murine model of systemic lupus erythematosus.
    Manderson AP; Carlucci F; Lachmann PJ; Lazarus RA; Festenstein RJ; Cook HT; Walport MJ; Botto M
    Arthritis Res Ther; 2006; 8(3):R68. PubMed ID: 16606442
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Apoptotic cell-mimicking gold nanocages loaded with LXR agonist for attenuating the progression of murine systemic lupus erythematosus.
    Xu N; Li J; Gao Y; Zhou N; Ma Q; Wu M; Zhang Y; Sun X; Xie J; Shen G; Yang M; Tu Q; Xu X; Zhu J; Tao J
    Biomaterials; 2019 Mar; 197():380-392. PubMed ID: 30703743
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Nitration of H2B histone elicits an immune response in experimental animals.
    Khan MA; Alam K; Hassan SM; Rizvi MMA
    Autoimmunity; 2017 Jun; 50(4):232-240. PubMed ID: 28737980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.